GlioCure
PrivateLast Round
Crowdfunding
Feb 15, 2024
Total Funding Raised
$1.64M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlioCure is a biotechnology company that develops neuro-oncology drugs and therapeutic peptides for the treatment of glioblastoma and other brain tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlioCure Comparables
Compare GlioCure with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PEP-Therapy | 80% | |
| PeptiMimesis | 79% | |
| MimiVax Inc. | 78% |
GlioCure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Feb 15, 2024 | ||||
| Seed | Dec 18, 2023 | ||||
| Grant | Feb 21, 2023 | ||||
| Debt | Apr 13, 2021 | ||||
| Seed | May 12, 2020 | ||||
Pre Seed | Oct 1, 2017 |
GlioCure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Happy Capital | Seed, Crowdfunding |
| ICO INNOV | Seed |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 106% MoM, reaching 2K.
- Nov 8, 2025
Monthly visitors grew 107% MoM.
Recent news
Latest coverage and updates
- declares_bankruptcySep 22, 2026
GlioCure SAS declared bankruptcy on Sep 22nd '26.
GlioCure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GlioCure's valuation, stock price, and market status.
Is GlioCure a public or private company?
GlioCure is a private company.
What is the current stock price of GlioCure?
GlioCure is a private company with no public stock price. Caplight tracks GlioCure's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is GlioCure worth (valuation)?
Valuation information for GlioCure is not publicly available.
Can I buy GlioCure stock?
GlioCure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GlioCure's last funding round?
GlioCure's most recent funding round was Crowdfunding on February 15, 2024.
Who are the main investors in GlioCure?
Key investors in GlioCure include Happy Capital, ICO INNOV, Bpifrance.
Will GlioCure IPO soon?
No public IPO plans have been announced for GlioCure.
How can I track GlioCure secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GlioCure's secondary market activity and sign up for updates.